Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Finkelstein

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nature Aging|August 8, 2022
Rethinking the urban physical environment for century-long lives: from age-friendly to longevity-ready citiesChenghao Wang, Diego Sierra Huertas, John W Rowe, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|October 25, 2025
Arts on Prescription for Older Adults: A Scoping ReviewS Sudha, Shayna Gleason, Joy Birabwa, et al.
Plant Science : an International Journal of Experimental Plant Biology|March 11, 2021
Phosphorylation of Serine 114 of the transcription factor ABSCISIC ACID INSENSITIVE 4 is essential for activityNadav Eisner, Tzofia Maymon, Ester Cancho Sanchez, et al.
AIDS Care|December 22, 2009
Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV careBruce R Schackman, Zubin Dastur, David S Rubin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborativeLinda Weiss, Julie Netherland, James E Egan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Initial strategies for integrating buprenorphine into HIV care settings in the United StatesLynn E Sullivan, Robert D Bruce, David Haltiwanger, et al.
Drug and Alcohol Dependence|January 29, 2008
Opioid use disorder in the United States: insurance status and treatment accessWilliam C Becker, David A Fiellin, Joseph O Merrill, et al.
Annals of Internal Medicine|June 2, 2010
Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trialGregory M Lucas, Amina Chaudhry, Jeffrey Hsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluationBruce R Schackman, Jared A Leff, Michael Botsko, et al.
Journal of Substance Abuse Treatment|August 22, 2008
Factors affecting willingness to provide buprenorphine treatmentJulie Netherland, Michael Botsko, James E Egan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature Aging|August 8, 2022
Rethinking the urban physical environment for century-long lives: from age-friendly to longevity-ready citiesChenghao Wang, Diego Sierra Huertas, John W Rowe, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|October 25, 2025
Arts on Prescription for Older Adults: A Scoping ReviewS Sudha, Shayna Gleason, Joy Birabwa, et al.
Plant Science : an International Journal of Experimental Plant Biology|March 11, 2021
Phosphorylation of Serine 114 of the transcription factor ABSCISIC ACID INSENSITIVE 4 is essential for activityNadav Eisner, Tzofia Maymon, Ester Cancho Sanchez, et al.
AIDS Care|December 22, 2009
Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV careBruce R Schackman, Zubin Dastur, David S Rubin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborativeLinda Weiss, Julie Netherland, James E Egan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Initial strategies for integrating buprenorphine into HIV care settings in the United StatesLynn E Sullivan, Robert D Bruce, David Haltiwanger, et al.
Drug and Alcohol Dependence|January 29, 2008
Opioid use disorder in the United States: insurance status and treatment accessWilliam C Becker, David A Fiellin, Joseph O Merrill, et al.
Annals of Internal Medicine|June 2, 2010
Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trialGregory M Lucas, Amina Chaudhry, Jeffrey Hsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2011
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluationBruce R Schackman, Jared A Leff, Michael Botsko, et al.
Journal of Substance Abuse Treatment|August 22, 2008
Factors affecting willingness to provide buprenorphine treatmentJulie Netherland, Michael Botsko, James E Egan, et al.
Pageof 4